Key result
NIP-142 at 100 µM significantly prolonged atrial action potential duration (APD90 from 76.5 to 93.0 ms) without prolonging ventricular APD, acting via blockade of the IKACh current.
Why the study?
Does NIP-142 prolong refractory period and action potential duration in isolated guinea pig myocardium and block I(KACh) in Xenopus oocytes?
Population
Isolated left atria and right ventricular papillary muscles or free walls from Hartley strain guinea pigs…
Comparison
NIP-142 (1 to 100 µM) vs Absence of drug, E-4031, 4-aminopyridine, and…
Design
Preclinical
Authors
Loading...
Hypothesis-generating for atrial-selective IKACh blockade in supraventricular arrhythmias; leaves open human translation and safety.
Does NIP-142 prolong refractory period and action potential duration in isolated guinea pig myocardium and block I(KACh) in Xenopus oocytes?
Absolute Event Rate: 93% vs 76.5%
p-value: p=<0.01
NIP-142 selectively prolongs atrial refractory period and action potential duration via I(KACh) blockade without reverse frequency dependence, highlighting its potential for treating supraventricular arrhythmias.
Matsuda et al. (2005) studied Atrial fibrillation (preclinical model). NIP-142 vs. Vehicle/Control (absence of drug) was evaluated on Atrial action potential duration at 90% repolarization (APD90) at 100 µM (p=<0.01). NIP-142 at 100 µM significantly prolonged atrial action potential duration (APD90 from 76.5 to 93.0 ms) without prolonging ventricular APD, acting via blockade of the IKACh current.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: